PCR Tech and IT retail, distribution and vendor news
RFID specialist, SML RFID, has launched its first DoseID certified inlay for pharmaceutical applications. The GB32U9 is equipped with the latest chip from NXP, UCODE9 and provides rapid inventory counting in dense RFID tag populations.
This inlay can track general pharmaceutical packages and easily fits on a wide range of pharmaceutical products, including small items such as plastic syringes, plastic vials, and other plastic materials containing liquid.
Its ultra small broad bandwidth antenna also measures 20x10mm with a wet paper face size of 26x12mm.
The GB32U9 inlay is DoseID certified, having met Auburn University ARC Lab’s Spec S. DoseID’s inlay certification ensures that serialized unit-of-use medications can be read accurately and reliably throughout a range of hospital pharmacy and inventory management workflows. For pharmaceutical manufacturers and 503B compounders looking to add DoseID to their products in plastic containers, the GB32U9 is the best business choice.
Dean Frew, Chief Technology Officer and Senior Vice President of RFID Solutions at SML Group said: “In an industry as critical as pharmaceutical and medicine, having an inaccurate view of inventory proves costly and needs to be addressed, and hospital pharmacies are looking to pharmaceutical manufacturers for solutions. The GB32U9 inlay is designed to alleviate these pain points and provide pharmaceutical manufacturers an easy solution to DoseID-enable their unit-of-use medications.”
Dr. Jeremy Liu, Vice President of RFID Technology, SML Group, commented: “The GB32U9 inlay provides a unique and innovative approach to inventory management for the pharmaceutical industry. Where smaller items with liquid around have previously been difficult to scan in hospital and supply chain workflows, the GB32U9’s ultra small size allows these organisations to obtain pinpoint accuracy. The compact design, combined with the sensitivity of the U9 chip, creates an inlay that caters perfectly to the demands of the pharmaceutical industry’s operations.”
Read the latest edition of PCR’s monthly magazine below:
Like this content? Sign up for the free PCR Daily Digest email service to get the latest tech news straight to your inbox. You can also follow PCR on Twitter and Facebook.
